Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stent portfolio, company officials reported today. It's the first time the FDA has approved a drug-eluting stent to treat blockages in a...
The first fully biodegradable coronary artery stent implanted in humans proved safe in a 10-year study published in Circulation, an American Heart Association journal. Stents are mesh tubes inserted into coronary arteries to help prop them open and allow for blood flow to the heart muscle. The...
A new way of opening blocked arteries in the brain using a removable stent system in people suffering strokes brought remarkably positive results in how those patients recovered from the strokes, according to a study presented at the American Stroke Association's annual conference in New...
Late breaking clinical trial results from testing of cangrelor, an investigational intravenous antiplatelet, showed patients can be "bridged" from the time that their physicians stop their oral antiplatelet drugs until they undergo cardiac surgery. Study results demonstrated cangrelor maintained...
Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the RX Herculink Elite® Renal Stent System for the treatment of renal artery stenosis (narrowing of the main arteries supplying blood to the kidneys) in patients with uncontrolled hypertension...
The addition of a simple stent can help prevent potentially lethal blood vessel bulges in the brain from recurring after they are repaired in a minimally invasive "coiling" procedure, according to new research by Johns Hopkins physicians. A report on the research, published in the July Journal...
Abbott Laboratory's RX ACCULINK Carotid Stent System outweighs its risks and patients with symptomatic and asymptomatic carotid artery diseases at standard surgical risk should be included in its usage, an FDA (Food and Drug Administration) Advisory Committee voted today; 7 in favor, 3 against...
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that a summary of the final clinical trial results for the randomized study of Cook Medical's Zilver® PTX® Drug-Eluting Peripheral Stent for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery...
Heart specialists at Southampton General Hospital are the first in Europe to implant an innovative 'slinky' coil to open a patient's blocked artery. Stents are used to create permanent blood flow in previously blocked arteries of coronary heart disease or heart attack patients during...
Boston Scientific Corporation (NYSE: BSX) has announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D...
Medical device pioneer Stentys announced today that the complete 'OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal...
Medical device pioneer Stentys announced today that the complete 'OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal...
A randomized multicenter study of 190 patients at 13 medical centers shows - for the first time - the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has...
A randomized multicenter study of 190 patients at 13 medical centers shows - for the first time - the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has...
A randomized multicenter study of 190 patients at 13 medical centers shows - for the first time - the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has...
A randomized multicenter study of 190 patients at 13 medical centers shows - for the first time - the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has...
A randomized multicenter study of 190 patients at 13 medical centers shows - for the first time - the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has...
A randomized multicenter study of 190 patients at 13 medical centers shows - for the first time - the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has...